| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.21B | +3.8% |
| R&D Expense | $144.0M | -4.0% |
| SG&A Expense | $1.88B | +6.9% |
| Operating Income | $2.19B | +7.5% |
| Interest Expense | $155.0M | +10.7% |
| Pre-tax Income | $2.03B | +7.6% |
| Income Tax | $533.0M | +2.7% |
| Net Income | $1.41B | +12.2% |
| EPS (Basic) | $3.42 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.27B | +7.1% |
| Accounts Receivable | $3.54B | +5.4% |
| Inventory | $612.0M | -0.8% |
| Current Assets | $6.40B | +4.2% |
| Total Assets | $10.12B | +3.0% |
| Current Liabilities | $6.48B | -5.3% |
| Long-term Debt | $6.87B | +3.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.63B | +4.3% |
| Investing Cash Flow | -$183.0M | -454.5% |
| Financing Cash Flow | -$1.35B | +63.0% |
| +14.8% |
| EPS (Diluted) | $3.39 | +14.5% |
| Total Liabilities |
| $14.84B |
| +2.4% |
| Stockholders' Equity | -$4.92B | -1.1% |